Serum thyroid-stimulating hormone receptor antibody levels and thyroid dysfunction after hysterosalpingography: a case-control study
Serum thyroid-stimulating hormone receptor antibody levels and thyroid dysfunction after hysterosalpingography: a case-control study
复制标题
子宫输卵管造影后血清促甲状腺激素受体抗体水平和甲状腺功能障碍:病例对照研究
DOI:
10.1080/09513590.2021.1963430
复制
发表时间:
2021
影响因子:
2
通讯作者:
Tawara Fumiko
中科院分区:
文献类型:
--
作者:
So Shuhei;Hashimoto Koshi;Mori Masatomo;Endo Shigeki;Yamaguchi Wakasa;Miyano Naomi;Murabayashi Nao;Tawara Fumiko
ObjectiveHysterosalpingography (HSG) performed with an iodine contrast media can cause thyroid dysfunction, including thyrotoxicosis and hypothyroidism. We investigated the association between the serum levels of thyroid-stimulating hormone receptor antibody (TRAb), an indicator of Graves’ disease, and abnormal thyroid function after performing HSG.MethodsThe screening of TRAb was conducted in 362 patients who first visited the Tawara IVF Clinic between April and September 2018. The association between TRAb levels and the effects of HSG examinations on thyroid function were evaluated.ResultsOf the 362 patients, 2 (0.55%) had high levels (>2.0 IU/L) of TRAb, whereas 18 (5.0%) had intermediate TRAb levels, ranging from 0.3 to 1.9 IU/L. Of the 98 women (including 7 of the 18 women with TRAb level 0.3–1.9 IU/L, and 91 of the 342 women with TRAb level <0.3 IU/L) who had undergone HSG, two women developed overt thyrotoxicosis after HSG, and the frequency was significantly higher (p= .0044) in the group with intermediate levels of TRAb (28.6%, 2 of 7) than that in the group with low TRAb levels (<0.3 IU/L; 0.0%, 0 of 91).ConclusionsThese findings indicate that increased serum levels of TRAb are significantly associated with the development of thyrotoxicosis after HSG.